ICU Medical CFO Brian Bonnell Sells Shares
On August 31, 2026, ICU Medical's Chief Financial Officer, Brian Michael Bonnell, sold 9,307 shares of the company at an average price of $172.79 per share through multiple transactions under a Rule 10b5-1 trading plan. The sale was part of a pre-established schedule and does not appear to signal any internal concerns about the firm's performance. Following this transaction, Bonnell still holds approximately 62,443 shares directly valued at $10.8 million as of August 31’s market close price ($172.95). This represents roughly 0.2% ownership in ICU Medical, a global medical technology company with a market cap of $3.8 billion and trailing twelve-month revenue of $2.2 billion. The stock has delivered strong returns recently, posting a one-period gain of 35% ending on August 31, as well as an annual return of nearly 19%. Analysts remain largely optimistic about the company's future with eight covering it and seven recommending a 'buy' rating.
Tickers: $ICUI